Refine
Year of publication
Document Type
- Article (109) (remove)
Has Fulltext
- yes (109)
Is part of the Bibliography
- no (109)
Keywords
- LHC (7)
- ALICE (3)
- ALICE experiment (3)
- HNSCC (3)
- Hadron-Hadron Scattering (3)
- Penile carcinomas (3)
- Radiotherapy (3)
- pp collisions (3)
- Beauty production (2)
- Breast cancer (2)
- Diagnostik (2)
- Früherkennung (2)
- Head and neck cancer (2)
- Mammakarzinom (2)
- Nachsorge (2)
- PD-L1 (2)
- Patterns of care (2)
- Richtlinie (2)
- Single electrons (2)
- Tumor microenvironment (2)
- aptamer (2)
- breast cancer (2)
- diagnosis (2)
- follow‑up (2)
- guideline (2)
- prostate cancer (2)
- screening (2)
- 900 GeV (1)
- Advanced breast cancer (1)
- Anal cancer (1)
- Anterior cingulate cortex (1)
- Antibodies (1)
- Antihormone therapy (1)
- Biomarker (1)
- Brain metastasis (1)
- CD8+ tumor infiltrating lymphocytes (1)
- COVID-19 (1)
- CUP (1)
- Cancer of unknown primary (1)
- Cancer treatment (1)
- Cell membranes (1)
- Central nervous system metastases (1)
- Cervical (1)
- Charm physics (1)
- Chemoradiotherapy (1)
- Clinical Trials and Observations (1)
- Comparison with QCD (1)
- DNA damage (1)
- D’Amico classification (1)
- E. coli (1)
- EGFR (1)
- Emotion (1)
- Empathy (1)
- FDG-PET/CT (1)
- Femtoscopy (1)
- First site of metastatic disease (1)
- Gleason score (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- HBT (1)
- HER2 c-erbB2 (1)
- HER2/neu (1)
- HIV (1)
- HPV infection (1)
- HPV-positive OPSCC (1)
- Hadron production (1)
- Head neck cancer (1)
- Heavy Ions (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Heregulin (1)
- IN-VIVO (1)
- Immunology (1)
- Immunophenotyping (1)
- Immunotherapy (1)
- Imrt (1)
- Inclusive spectra (1)
- Induction therapy (1)
- Intensity interferometry (1)
- Jets (1)
- Juvenile myoclonic epilepsy (1)
- LCD-Array (1)
- LOCKED NUCLEIC-ACID (1)
- LTP (1)
- Lee-type (1)
- Lesions (1)
- Library screening (1)
- Loco-regional control (1)
- Luciferase (1)
- Lymph node (1)
- Lymphocyte subpopulations (1)
- Lymphoid Neoplasia (1)
- MAMMALIAN-CELLS (1)
- MM-121 (1)
- MODIFIED OLIGONUCLEOTIDES (1)
- Machine learning (1)
- Metastatic (1)
- Mid-rapidity (1)
- Molecular diagnostics (1)
- Mott metal-insulator transition (1)
- Multi-strange baryons (1)
- NK cell subsets (1)
- NMR spectroscopy (1)
- Nanoscale materials (1)
- Necrosis (1)
- Non-small cell lung cancer (1)
- Nuclear modification factor (1)
- Oncology (1)
- PASSENGER-STRAND (1)
- PYTHIA (1)
- Pb–Pb (1)
- Phosphorylation (1)
- Prediction of locoregional recurrence (1)
- Proton–proton (1)
- Pupillometry (1)
- Radiation Oncology (1)
- Radiochemotherapy (1)
- Radiomics (1)
- Real-time polymerase chain reaction (PCR) tests (1)
- Relativistic heavy ion physics (1)
- SARS-CoV-2 testing (1)
- SCCHN (1)
- SELEX (1)
- SMALL INTERFERING RNA (1)
- STRUCTURAL BASIS (1)
- Salivary gland cancer (1)
- Salivary gland carcinoma (1)
- Sanger Sequencing (1)
- Screening (1)
- Seribantumab (1)
- Single muons (1)
- Small molecules (1)
- Stereotactic ablative body radiotherapy (1)
- Stereotactic radiosurgery (1)
- Surgery (1)
- Survey (1)
- Survival (1)
- Systemic therapy (1)
- T-DM1 (1)
- TKI (1)
- Tissue microarray (1)
- Toxicity (1)
- Transverse momentum (1)
- Urological oncology (1)
- Validation (1)
- Vesicles (1)
- Viral infection (1)
- Viral oncology (1)
- X-ray diffraction (1)
- activated factor XIII (1)
- advanced breast cancer (1)
- aging (1)
- amino acids (1)
- amyloid precursor protein (1)
- anal cancer (1)
- antibodies (1)
- anticoagulants (1)
- antihormone therapy (1)
- apex (1)
- aptamer modeling (1)
- artificial magnetic lattices (1)
- b-cell lymphomas (1)
- bendamustine (1)
- biophysics (1)
- blood coagulation (1)
- cancer-specific survival (1)
- caspase 8 (1)
- cell biology (1)
- cervical cancer (1)
- cetuximab (1)
- charge-cluster glass (1)
- chemoradiotherapy (1)
- chemotherapy (1)
- chemotherapy regimen (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- coagulation process (1)
- combined modality therapy (1)
- diffusion-weighted magnetic resonance imaging (1)
- double immune checkpoint inhibition (1)
- fMRI (1)
- fluctuation spectroscopy (1)
- focused electron beam induced deposition (1)
- functional outcome (1)
- gene signature (1)
- glass-like structural ordering (1)
- head and neck cancer (1)
- head and neck neoplasms (1)
- head and neck squamous cell carcinoma (1)
- hematopoietic stem cell transplantation (1)
- hippocampus (1)
- image-based risk modelling (1)
- immune-checkpoint inhibition (1)
- immunotherapy (1)
- induction therapy (1)
- inverse stage migration (1)
- kinetically trapped state (1)
- lapatinib (1)
- leukapheresis (1)
- leukopenia (1)
- local control (1)
- lymphoma (1)
- mTOR (1)
- machine learning (1)
- magnetic nanostructures (1)
- membranous urethra (1)
- merkel cell carcinoma (1)
- metastatic (1)
- micro-Hall magnetometry (1)
- micromagnetic simulations (1)
- mid-term urinary continence (1)
- mitochondria (1)
- mouse (1)
- multiplexed immunofluorescence (1)
- neoadjuvant chemoradiotherapy (1)
- nucleic acid docking (1)
- oligonucleotide (1)
- oocytes (1)
- oral cavity cancer (1)
- organ preservation (1)
- organic charge-transfer salts (1)
- outcome (1)
- overall survival (1)
- p16 (1)
- p63 (1)
- percolation (1)
- personalised therapy (1)
- pertuzumab (1)
- photocaging (1)
- phototherapeutic window (1)
- polo-like kinase 3 (1)
- polyomavirus (MCPyV) (1)
- postoperative radiochemotherapy (1)
- postoperative radiotherapy (1)
- predictive biomarker (1)
- presynaptic active zone (1)
- propensity score matching (1)
- proteins (1)
- quality control (1)
- radiation oncology (1)
- radical prostatecomy (1)
- radical prostatectomy (1)
- radioimmunotherpay (1)
- radiomic (1)
- re-irradiation (1)
- red light (1)
- rituximab (1)
- sarcopenia (1)
- spectra (1)
- spring-loaded activation (1)
- structural biolog (1)
- structure elucidation (1)
- targeted therapy (1)
- thrombin (1)
- thrombopenia (1)
- toxicity (1)
- transglutaminase (1)
- trastuzumab (1)
- √sN N = 2.76 TeV (1)
Institute
The inclusive charged particle transverse momentum distribution is measured in proton–proton collisions at s=900 GeV at the LHC using the ALICE detector. The measurement is performed in the central pseudorapidity region (|η|<0.8) over the transverse momentum range 0.15<pT<10 GeV/c. The correlation between transverse momentum and particle multiplicity is also studied. Results are presented for inelastic (INEL) and non-single-diffractive (NSD) events. The average transverse momentum for |η|<0.8 is 〈pT〉INEL=0.483±0.001 (stat.)±0.007 (syst.) GeV/c and 〈pT〉NSD=0.489±0.001 (stat.)±0.007 (syst.) GeV/c, respectively. The data exhibit a slightly larger 〈pT〉 than measurements in wider pseudorapidity intervals. The results are compared to simulations with the Monte Carlo event generators PYTHIA and PHOJET.
Harmonic decomposition of two particle angular correlations in Pb–Pb collisions at √sNN=2.76 TeV
(2012)
Angular correlations between unidentified charged trigger (t) and associated (a) particles are measured by the ALICE experiment in Pb–Pb collisions at √sNN=2.76 TeV for transverse momenta 0.25<pTt,a<15 GeV/c, where pTt>pTa. The shapes of the pair correlation distributions are studied in a variety of collision centrality classes between 0 and 50% of the total hadronic cross section for particles in the pseudorapidity interval |η|<1.0. Distributions in relative azimuth Δϕ≡ϕt−ϕa are analyzed for |Δη|≡|ηt−ηa|>0.8, and are referred to as “long-range correlations”. Fourier components VnΔ≡〈cos(nΔϕ)〉 are extracted from the long-range azimuthal correlation functions. If particle pairs are correlated to one another through their individual correlation to a common symmetry plane, then the pair anisotropy VnΔ(pTt,pTa) is fully described in terms of single-particle anisotropies vn(pT) as VnΔ(pTt,pTa)=vn(pTt)vn(pTa). This expectation is tested for 1⩽n⩽5 by applying a global fit of all VnΔ(pTt,pTa) to obtain the best values vn{GF}(pT). It is found that for 2⩽n⩽5, the fit agrees well with data up to pTa∼3–4 GeV/c, with a trend of increasing deviation as pTt and pTa are increased or as collisions become more peripheral. This suggests that no pair correlation harmonic can be described over the full 0.25<pT<15 GeV/c range using a single vn(pT) curve; such a description is however approximately possible for 2⩽n⩽5 when pTa<4 GeV/c. For the n=1 harmonic, however, a single v1(pT) curve is not obtained even within the reduced range pTa<4 GeV/c.
Rapidity and transverse momentum dependence of inclusive J/ψ production in pp collisions at √s=7 TeV
(2011)
The ALICE experiment at the LHC has studied inclusive J/ψ production at central and forward rapidities in pp collisions at √s=7 TeV. In this Letter, we report on the first results obtained detecting the J/ψ through the dilepton decay into e+e− and μ+μ− pairs in the rapidity ranges |y|<0.9 and 2.5<y<4, respectively, and with acceptance down to zero pT. In the dielectron channel the analysis was carried out on a data sample corresponding to an integrated luminosity Lint=5.6 nb−1 and the number of signal events is NJ/ψ=352±32(stat.)±28(syst.); the corresponding figures in the dimuon channel are Lint=15.6 nb−1 and NJ/ψ=1924±77(stat.)±144(syst.). The measured production cross sections are σJ/ψ(|y|<0.9)=10.7±1.0(stat.)±1.6(syst.)−2.3+1.6(syst.pol.)μb and σJ/ψ(2.5<y<4)=6.31±0.25(stat.)±0.76(syst.)−1.96+0.95(syst.pol.)μb. The differential cross sections, in transverse momentum and rapidity, of the J/ψ were also measured.
The first measurement of two-pion Bose–Einstein correlations in central Pb–Pb collisions at √sNN=2.76 TeV at the Large Hadron Collider is presented. We observe a growing trend with energy now not only for the longitudinal and the outward but also for the sideward pion source radius. The pion homogeneity volume and the decoupling time are significantly larger than those measured at RHIC.
Inclusive transverse momentum spectra of primary charged particles in Pb–Pb collisions at √sNN=2.76 TeV have been measured by the ALICE Collaboration at the LHC. The data are presented for central and peripheral collisions, corresponding to 0–5% and 70–80% of the hadronic Pb–Pb cross section. The measured charged particle spectra in |η|<0.8 and 0.3<pT<20 GeV/c are compared to the expectation in pp collisions at the same sNN, scaled by the number of underlying nucleon–nucleon collisions. The comparison is expressed in terms of the nuclear modification factor RAA. The result indicates only weak medium effects (RAA≈0.7) in peripheral collisions. In central collisions, RAA reaches a minimum of about 0.14 at pT=6–7 GeV/c and increases significantly at larger pT. The measured suppression of high-pT particles is stronger than that observed at lower collision energies, indicating that a very dense medium is formed in central Pb–Pb collisions at the LHC.
The ALICE experiment has measured low-mass dimuon production in pp collisions at √s=7 TeV in the dimuon rapidity region 2.5<y<4. The observed dimuon mass spectrum is described as a superposition of resonance decays (η,ρ,ω,η′,ϕ) into muons and semi-leptonic decays of charmed mesons. The measured production cross sections for ω and ϕ are σω(1<pt<5 GeV/c,2.5<y<4)=5.28±0.54(stat)±0.49(syst) mb and σϕ(1<pt<5 GeV/c,2.5<y<4)=0.940±0.084(stat)±0.076(syst) mb. The differential cross sections d2σ/dydpt are extracted as a function of pt for ω and ϕ. The ratio between the ρ and ω cross section is obtained. Results for the ϕ are compared with other measurements at the same energy and with predictions by models.
he first measurements of the invariant differential cross sections of inclusive π0 and η meson production at mid-rapidity in proton–proton collisions at s=0.9 TeV and s=7 TeV are reported. The π0 measurement covers the ranges 0.4<pT<7 GeV/c and 0.3<pT<25 GeV/c for these two energies, respectively. The production of η mesons was measured at s=√7 TeV in the range 0.4<pT<15 GeV/c. Next-to-Leading Order perturbative QCD calculations, which are consistent with the π0 spectrum at s=0.9 TeV, overestimate those of π0 and η mesons at s=√7 TeV, but agree with the measured η/π0 ratio at s=√7 TeV.
The ALICE Collaboration has made the first measurement at the LHC of J/ψ photoproduction in ultra-peripheral Pb–Pb collisions at sNN=2.76 TeV. The J/ψ is identified via its dimuon decay in the forward rapidity region with the muon spectrometer for events where the hadronic activity is required to be minimal. The analysis is based on an event sample corresponding to an integrated luminosity of about 55 μb−1. The cross section for coherent J/ψ production in the rapidity interval −3.6<y<−2.6 is measured to be dσJ/ψcoh/dy=1.00±0.18(stat)−0.26+0.24(syst) mb. The result is compared to theoretical models for coherent J/ψ production and found to be in good agreement with those models which include nuclear gluon shadowing.
Identical neutral kaon pair correlations are measured in √s=7 TeV pp collisions in the ALICE experiment. One-dimensional Ks0Ks0 correlation functions in terms of the invariant momentum difference of kaon pairs are formed in two multiplicity and two transverse momentum ranges. The femtoscopic parameters for the radius and correlation strength of the kaon source are extracted. The fit includes quantum statistics and final-state interactions of the a0/f0 resonance. Ks0Ks0 correlations show an increase in radius for increasing multiplicity and a slight decrease in radius for increasing transverse mass, mT, as seen in ππ correlations in pp collisions and in heavy-ion collisions. Transverse mass scaling is observed between the Ks0Ks0 and ππ radii. Also, the first observation is made of the decay of the f2′(1525) meson into the Ks0Ks0 channel in pp collisions.